Mealey's (January 3, 2023, 3:57 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration has issued a drug safety communication that it is investigating the risk of severe hypocalcemia with serious outcomes including hospitalization and death in patients with advanced kidney disease who are treated with the osteoporosis drug Prolia....